🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Qi Zhang

ORCID: 0000-0002-7918-8952
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials”.

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

Nature Medicine(2023)10.1038/s41591-022-02103-8
N/A
4.3DataRank · unranked
388 citations

Naval Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric‐Bernstam +44 more

Selective Inhibition of the Second Bromodomain of BET Family Proteins Results in Robust Antitumor Activity in Preclinical Models of Acute Myeloid Leukemia

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0029
N/A
1.4DataRank · unranked
34 citations

Tianyu Cai, Xia Li, Xiaoli Huang, Mai H. Bui, Joshua P. Plotnik +26 more

Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells

Nature Communications(2022)10.1038/s41467-022-29669-8
N/A
0DataRank · unranked
43 citations

Agnès Gouble, Kathryn L. Black, Anna Skwarska, Ammar S. Naqvi, Deanne Taylor +28 more

Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy

Haematologica(2022)10.3324/haematol.2022.280884
N/A
0DataRank · unranked
28 citations

Guopan Yu, Hongying Zhang, Mahesh Basyal, Charlie Ly, Bin Yuan +10 more

Maximal Activation of Apoptosis Signaling by Cotargeting Antiapoptotic Proteins in BH3 Mimetic–Resistant AML and AML Stem Cells

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0690
N/A
0DataRank · unranked
16 citations

Po Yee Mak, Wenjing Tao, Qi Zhang, Vivian Ruvolo, Vinitha M. Kuruvilla +10 more

Targeting Oxidative Phosphorylation with a Mitochondrial Complex I Inhibitor is limited by Mechanism-based Toxicity

Research Square(2022)10.21203/rs.3.rs-1506700/v1
N/A
0DataRank · unranked
5 citations

Timothy A. Yap, Naval Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka +43 more

FLT3 inhibitors upregulate CXCR4 and E-selectin ligands through suppression of ERK in AML and combined inhibition of CXCR4/E-selectin enhances anti-leukemia efficacy of FLT3-targeted therapy

Research Square(2022)10.21203/rs.3.rs-2277452/v1
N/A
0DataRank · unranked
1 citations

Weiguo Zhang, Mahesh Basyal, Kyung Hee Chang, Lauren B. Ostermann, Jared K. Burks +11 more

Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells

Haematologica(2023)10.3324/haematol.2022.281915
N/A
0DataRank · unranked
68 citations

Lina Han, Cassandra L. Ramage, Zhe Wang, Connie C. Weng, Lei Yang +15 more

Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous Leukemia

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-22-0343
N/A
0DataRank · unranked
16 citations

Sujan Piya, Huaxian Ma, Priyanka Sharma, Qi Zhang, Natalia Baran +10 more

FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML

Leukemia(2023)10.1038/s41375-023-01897-x
N/A
0DataRank · unranked
19 citations

Weiguo Zhang, Mahesh Basyal, Kyung Hee Chang, Lauren B. Ostermann, Jared K. Burks +11 more

Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL

Leukemia(2023)10.1038/s41375-023-02010-y
N/A
0DataRank · unranked
10 citations

Chunhua Shi, Guojun Yang, Jason Allen, Qing Shi, Amin Al-Shami +15 more

BCL-2 inhibition in acute myeloid leukemia: resistance and combinations

Expert Review of Hematology(2024)10.1080/17474086.2024.2429604
N/A
0DataRank · unranked
8 citations

Zhe Wang, Marina Konopleva, Qi Zhang

Increased endothelial sclerostin caused by elevated DSCAM mediates multiple trisomy 21 phenotypes

Journal of Clinical Investigation(2024)10.1172/jci167811
N/A
0DataRank · unranked
6 citations

Qi Zhang, Priyanka Narayan, Sarah U. Morton, Viktoria Strohmenger, Vi T. Tang +18 more

Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity,

Nature Communications(2021)10.1038/s41467-021-27210-x
N/A
0DataRank · unranked
149 citations

Pratik Pal, Xingui Liu, Yannan Jia, Dinesh Thummuri, Peiyi Zhang +19 more

BH3 Mimetics Augment Cytotoxic T Cell Killing of Acute Myeloid Leukemia via Mitochondrial Apoptotic Mechanism

Research Square(2024)10.21203/rs.3.rs-5307127/v1
N/A
0DataRank · unranked
0 citations

Kapil Saxena, Esther Ryu, Shao-Hsi Hung, Shailbala Singh, Qi Zhang +4 more

Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia

Signal Transduction and Targeted Therapy(2022)10.1038/s41392-021-00870-3
N/A
0DataRank · unranked
186 citations

Bridget Riley‐Gillis, Lina Han, Yannan Jia, Alessia Lodi, Haijiao Zhang +36 more